XBiotech, Inc. (XBIT)
2.20
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
2.20
0.00 (0.00%)
After-Hours: 20:00
XBiotech Shareholders Equity (Quarterly) : 128.46M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 128.46M |
| March 31, 2026 | 135.02M |
| December 31, 2025 | 140.35M |
| September 30, 2025 | 167.08M |
| June 30, 2025 | 173.06M |
| March 31, 2025 | 174.71M |
| December 31, 2024 | 182.27M |
| September 30, 2024 | 192.12M |
| June 30, 2024 | 196.70M |
| March 31, 2024 | 209.28M |
| December 31, 2023 | 218.85M |
| September 30, 2023 | 222.66M |
| June 30, 2023 | 229.06M |
| March 31, 2023 | 236.90M |
| December 31, 2022 | 240.40M |
| September 30, 2022 | 244.81M |
| June 30, 2022 | 255.80M |
| March 31, 2022 | 265.56M |
| December 31, 2021 | 269.38M |
| September 30, 2021 | 274.16M |
| June 30, 2021 | 348.56M |
| March 31, 2021 | 352.10M |
| December 31, 2020 | 348.64M |
| September 30, 2020 | 346.14M |
| June 30, 2020 | 343.57M |
| Date | Value |
|---|---|
| March 31, 2020 | 347.08M |
| December 31, 2019 | 755.63M |
| September 30, 2019 | 64.62M |
| June 30, 2019 | 69.41M |
| March 31, 2019 | 36.98M |
| December 31, 2018 | 41.40M |
| September 30, 2018 | 46.94M |
| June 30, 2018 | 51.52M |
| March 31, 2018 | 56.41M |
| December 31, 2017 | 60.16M |
| September 30, 2017 | 67.15M |
| June 30, 2017 | 73.16M |
| March 31, 2017 | 82.27M |
| December 31, 2016 | 59.06M |
| September 30, 2016 | 71.63M |
| June 30, 2016 | 82.80M |
| March 31, 2016 | 94.68M |
| December 31, 2015 | 103.05M |
| September 30, 2015 | 114.08M |
| June 30, 2015 | 123.98M |
| March 31, 2015 | 54.86M |
| December 31, 2014 | 59.03M |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 133.65M |
| Total Liabilities (Quarterly) | 5.19M |
| Current Ratio | 33.15 |